I am currently a Lecturer in Neuroscience within Aston Pharmacy School and am Associate Director "Rare Disease and Clinical Populations" Research Theme Lead for the Aston Institute of Health and Neurodevelopment (IHN).

Previously, I have held multiple post-doctoral research roles within the IHN and was also a Lecturer in Psychology (teaching-focussed, .2FTE) for Aston Medical School.

Understanding consequences of neurological diseases on the still-developing brain using cognitive neuroscience methods: Magnetic Resonance Imaging, Magnetoencephalography and Neuropsychology.

I am interested in understanding brain and cognitive development in children, using neuroimaging and neuropsychological methods, and how these are influenced by the presence of chronic neurological disease. I have a keen interest in developing this further with the added value that longitudinal data can bring.

I will use this knowledge to develop early warning systems and predictive models of a wide range of clinical and functional outcomes which matter to families.  These will become clinical support tools to inform treatment, and management in these populations to maximise the developmental outcomes of these children.

My current work focusses on using MRI and MEG neuroimaging methods, as well as digital (app-based) health-monitoring in patient groups with demyelinating syndromes, where disease mechanisms attack the brain's wiring,

My previous PostDoc experience fits into into this ‘vision’:

• Paediatric Brain Tumour Diagnosis – Performing ROI analysis using MRI and deep learning to predict tumour diagnosis from in-vivo imaging, ahead of histopathology. Providing this information ahead of time will influence decision making and clinical management.
• MEGMOG – Investigating the use of MEG as a potential novel biomarker in MOG-antibody associated disease. Identifying changes in functional brain networks as neural correlates of disease severity and cognitive outcomes.
• PROBIT - Predicting long-term outcomes of pediatric brain insult using MRI. Developing transdiagnostic models which can predict outcomes that matter to families including academic achievement, behavioural difficulties and cognition.

• Associate Fellow and Chartered member of the British Psychological Society (AFBPsS, CPsychol; Membership No. 338022)
• Honorary (Research) contract with Birmingham Children’s Hospital (2018-Present)
• Associate Fellow of the Higher Education Academy (Ref: PR223179)

NE3520 / NE4IMA : Imaging Studies in Neurodevelopment

My final year module on the BSc Neuroscience course is focussed on understanding how neuroimaging (with a specific focus on brain structure and function using MRI and MEG) can inform us about neurodevelopmental disorders, such as ADHD or Autism. 

Dr Griffiths-King's research focuses on understanding brain, cognitive development in children, using neuroimaging and neuropsychological methods.